Company attributes
Industry
Location
B2X
Founder
Legal Name
ViaCyte, Inc.
Date Incorporated
December 20, 1999
Number of Employees (Ranges)
51 – 200
Email Address
info@viacyte.com0
media@viacyte.com0
ir@viacyte.com0
Phone Number
+185820705000
+18584553708
+16173416100
Full Address
5580 Morehouse Drive, Suite 100 San Diego, CA 921210
CIK Number
Place of Incorporation
Investors
DUNS Number
791779838
IRS Number
330,884,1720
Founded Date
1999
Fax Number
+1-858.207.50010
Total Funding Amount (USD)
328,800,000
Latest Funding Round Date
June 18, 2021
Competitors
Board of Directors
CFO
Former CEO
Latest Funding Type
CAGE Code
4TRD60
Patents Assigned (Count)
1
Technologies Used
Country
Other attributes
Company Operating Status
Active
Contact Page URL
Latest Funding Round Amount (USD)
45,000,000
Previous Name
Novocell0
SIC Code
2,8340
ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes that is headquartered in San Diego, California and was founded in 1999 by Paul Laikind.
Timeline
No Timeline data yet.
